First person gets new experimental vaccine for Ebola
The world's first vaccine targeting the Bundibugyo ebolavirus has entered human clinical trials following the first volunteer vaccination.
7 independently sourced, verified trend briefs about this subject.
Newsylist includes a story here only after at least four independent sources support it and its brief passes the verification check. The qualifying coverage spans 2 news categories, from Jun 23, 2026 through Jul 25, 2026.
The cards below are ordered newest first. Each opens the underlying timeline, source list, coverage velocity and verification context; raw or extractive-only records are excluded.
The world's first vaccine targeting the Bundibugyo ebolavirus has entered human clinical trials following the first volunteer vaccination.
A first-in-human clinical trial for a mutant KRAS vaccine shows promise in preventing pancreatic cancer among high-risk patients.
UCSF has begun screening patients for a novel trial testing whether a combination of two drugs is more effective against Alzheimer's than a single treatment.
Compass Pathways reports positive six-month data for its psilocybin-based depression treatment, fueling market confidence and future filing plans.
Clinical trials are underway to address a viral strain of Ebola currently affecting the Democratic Republic of Congo for which no specific treatment exists.
An experimental drug targeting pancreatic cancer is showing promising survival gains in clinical trials.
The U.S. Department of Health and Human Services is launching a department-wide effort to accelerate clinical trials and restore American leadership in medical research.